ContraFect's Series C Round

ContraFect raised a round of funding on September 15, 2011. Investors include Equity Source Partners.

ContraFect is a biotechnology company committed to developing technologies, treatments, and products that will target and kill the most virulent and resistant microorganisms-including gram-positive ba…

Articles about ContraFect's Series C Round: